Meeting
Abstract Number: 138
SHM Converge 2024
Background: Rhabdomyosarcoma (RMS) is an exceptionally rare soft tissue sarcoma that exhibits significantly lower survival rates in adults when compared to pediatric patients. This disparity is likely attributed to a combination of histopathological variations, delayed, or missed diagnoses, and treatment-related factors(1). Notably, adult RMS originating from the extremities is classified as “unfavorable” and has been […]